Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies
Abstract Background: Breast cancer therapy has been facing remarkable changes. Classic treatments are now combined with other therapies to improve…
Cristina Amaral
Cannabidivarin and cannabigerol induce unfolded protein response and angiogenesis dysregulation in placental trophoblast HTR-8/SVneo cells
Abstract Cannabidivarin (CBDV) and cannabigerol (CBG) are minor phytocannabinoids from Cannabis sativa, whose health benefits have been reported. However, studies…
Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors
Abstract Simple Summary: Estrogen receptor-positive (ER+) breast cancer is the most prevalent breast cancer subtype, accounting for 70–85% of all…
Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype
Abstract Although cannabinoids have been used for centuries for diverse pathological conditions, recently, their clinical interest and application have emerged…